rs149367557
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_021098.3(CACNA1H):c.5024G>A(p.Arg1675Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000962 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1675L) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5039G>A | p.Arg1680Gln | missense_variant | Exon 27 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5042G>A | p.Arg1681Gln | missense_variant | Exon 27 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5006G>A | p.Arg1669Gln | missense_variant | Exon 27 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5039G>A | p.Arg1680Gln | missense_variant | Exon 28 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.4985G>A | p.Arg1662Gln | missense_variant | Exon 28 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5006G>A | p.Arg1669Gln | missense_variant | Exon 27 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.4967G>A | p.Arg1656Gln | missense_variant | Exon 27 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5006G>A | p.Arg1669Gln | missense_variant | Exon 27 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5024G>A | p.Arg1675Gln | missense_variant | Exon 28 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5024G>A | non_coding_transcript_exon_variant | Exon 28 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*976G>A | non_coding_transcript_exon_variant | Exon 27 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*105G>A | non_coding_transcript_exon_variant | Exon 28 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2875G>A | non_coding_transcript_exon_variant | Exon 28 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4468G>A | non_coding_transcript_exon_variant | Exon 26 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.5006G>A | non_coding_transcript_exon_variant | Exon 27 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.5006G>A | non_coding_transcript_exon_variant | Exon 27 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*25G>A | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.5024G>A | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.5024G>A | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5006G>A | non_coding_transcript_exon_variant | Exon 27 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5024G>A | non_coding_transcript_exon_variant | Exon 28 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5024G>A | non_coding_transcript_exon_variant | Exon 28 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*25G>A | non_coding_transcript_exon_variant | Exon 27 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*976G>A | 3_prime_UTR_variant | Exon 27 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*105G>A | 3_prime_UTR_variant | Exon 28 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2875G>A | 3_prime_UTR_variant | Exon 28 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4468G>A | 3_prime_UTR_variant | Exon 26 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*25G>A | 3_prime_UTR_variant | Exon 28 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*25G>A | 3_prime_UTR_variant | Exon 27 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152152Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000123 AC: 30AN: 244404 AF XY: 0.000120 show subpopulations
GnomAD4 exome AF: 0.0000973 AC: 142AN: 1459654Hom.: 0 Cov.: 32 AF XY: 0.000110 AC XY: 80AN XY: 725914 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74450 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1675 of the CACNA1H protein (p.Arg1675Gln). This variant is present in population databases (rs149367557, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with seizures (PMID: 27066544). This variant is also known as p.Arg1669Gln. ClinVar contains an entry for this variant (Variation ID: 571604). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CACNA1H protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Identified in a patient with epilepsy with auditory features who inherited the variant from a parent with sleep-related bilateral tonic-clonic seizures (Pippucci et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27066544) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at